Sphera Funds Management as of Sept. 30, 2016
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 107 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p Oil & Gas Exp & Pr put | 17.3 | $106M | 1.6M | 66.29 | |
Ishares Tr Index option | 9.4 | $58M | 200k | 289.46 | |
Merck & Co (MRK) | 3.0 | $19M | 300k | 62.41 | |
Teva Pharmaceutical Industries (TEVA) | 3.0 | $19M | 402k | 46.01 | |
Sarepta Therapeutics (SRPT) | 2.6 | $16M | 263k | 61.41 | |
Allergan | 2.6 | $16M | 70k | 230.31 | |
Eli Lilly & Co. (LLY) | 2.6 | $16M | 200k | 80.26 | |
Biogen Idec (BIIB) | 2.5 | $16M | 50k | 313.04 | |
Colucid Pharmaceuticals | 2.5 | $15M | 400k | 38.15 | |
Pfizer (PFE) | 2.4 | $14M | 427k | 33.87 | |
Ituran Location And Control (ITRN) | 2.0 | $12M | 457k | 26.46 | |
Celgene Corporation | 1.9 | $12M | 110k | 104.53 | |
Amgen (AMGN) | 1.8 | $11M | 66k | 166.81 | |
Horizon Pharma | 1.6 | $9.7M | 535k | 18.13 | |
Gilead Sciences (GILD) | 1.4 | $8.9M | 113k | 79.12 | |
Alexion Pharmaceuticals | 1.4 | $8.6M | 70k | 122.54 | |
Mylan Nv | 1.2 | $7.6M | 200k | 38.12 | |
Biomarin Pharmaceutical | 1.2 | $7.4M | 80k | 92.52 | |
Sage Therapeutics (SAGE) | 1.2 | $7.3M | 160k | 46.05 | |
Amicus Therapeutics (FOLD) | 1.1 | $6.7M | 905k | 7.40 | |
AstraZeneca (AZN) | 1.1 | $6.6M | 200k | 32.86 | |
Achaogen | 1.0 | $6.2M | 1.3M | 4.79 | |
Array BioPharma | 1.0 | $6.1M | 900k | 6.75 | |
Nice Systems (NICE) | 0.9 | $5.8M | 86k | 66.95 | |
Corvus Pharmaceuticals (CRVS) | 0.9 | $5.3M | 325k | 16.45 | |
Ascendis Pharma A S (ASND) | 0.9 | $5.3M | 264k | 20.10 | |
Glycomimetics (GLYC) | 0.8 | $5.1M | 718k | 7.15 | |
Tesaro | 0.8 | $5.0M | 50k | 100.24 | |
Eiger Biopharmaceuticals | 0.8 | $5.0M | 374k | 13.39 | |
Neuroderm Ltd F | 0.8 | $4.7M | 254k | 18.49 | |
Adamas Pharmaceuticals | 0.7 | $4.4M | 270k | 16.41 | |
Charter Communications Inc New Cl A cl a (CHTR) | 0.7 | $4.4M | 16k | 269.97 | |
Retrophin | 0.7 | $4.3M | 190k | 22.38 | |
Gw Pharmaceuticals Plc ads | 0.7 | $4.1M | 31k | 132.74 | |
Avexis | 0.7 | $4.1M | 100k | 41.21 | |
ACADIA Pharmaceuticals (ACAD) | 0.7 | $4.0M | 125k | 31.81 | |
Selecta Biosciences (RNAC) | 0.7 | $4.0M | 285k | 14.01 | |
Clearside Biomedical (CLSD) | 0.6 | $3.9M | 226k | 17.35 | |
Macrogenics (MGNX) | 0.6 | $3.9M | 130k | 29.91 | |
Alphabet Inc Class A cs (GOOGL) | 0.6 | $3.9M | 4.8k | 804.07 | |
Inotek Pharmaceuticals | 0.6 | $3.8M | 402k | 9.48 | |
Fidelity National Information Services (FIS) | 0.6 | $3.7M | 48k | 77.03 | |
Alder Biopharmaceuticals | 0.6 | $3.7M | 113k | 32.77 | |
Union Pacific Corporation (UNP) | 0.6 | $3.6M | 37k | 97.52 | |
Visa (V) | 0.6 | $3.5M | 43k | 82.70 | |
Orbotech Ltd Com Stk | 0.6 | $3.4M | 116k | 29.61 | |
Air Products & Chemicals (APD) | 0.5 | $3.2M | 21k | 150.34 | |
Foamix Pharmaceuticals | 0.5 | $3.2M | 342k | 9.26 | |
Gilead Sciences Inc option | 0.5 | $3.1M | 39k | 79.13 | |
Five Prime Therapeutics | 0.5 | $3.1M | 60k | 52.48 | |
Genocea Biosciences | 0.5 | $3.1M | 609k | 5.12 | |
Acorda Therapeutics | 0.5 | $3.1M | 148k | 20.88 | |
Endo International (ENDPQ) | 0.5 | $3.0M | 150k | 20.15 | |
Fibrogen (FGEN) | 0.5 | $3.0M | 146k | 20.70 | |
Aldeyra Therapeutics (ALDX) | 0.5 | $2.9M | 369k | 7.85 | |
Dbv Technologies S A (DBVT) | 0.5 | $2.9M | 79k | 36.33 | |
Snap-on Incorporated (SNA) | 0.5 | $2.8M | 18k | 151.96 | |
Apple Inc option | 0.5 | $2.8M | 19k | 149.14 | |
Kite Pharma | 0.5 | $2.8M | 50k | 55.86 | |
Audentes Therapeutics | 0.4 | $2.7M | 150k | 17.81 | |
Forward Pharma A/s | 0.4 | $2.6M | 122k | 21.00 | |
Ishares Tr Index option | 0.4 | $2.5M | 21k | 124.20 | |
Medgenics | 0.4 | $2.5M | 450k | 5.57 | |
Syndax Pharmaceuticals (SNDX) | 0.4 | $2.5M | 166k | 15.16 | |
Versartis | 0.4 | $2.5M | 200k | 12.25 | |
Marinus Pharmaceuticals | 0.4 | $2.4M | 1.3M | 1.82 | |
Dermira | 0.4 | $2.4M | 70k | 33.81 | |
Catabasis Pharmaceuticals | 0.4 | $2.4M | 388k | 6.16 | |
Starbucks Corporation (SBUX) | 0.4 | $2.3M | 42k | 54.13 | |
Vistagen Therapeutics | 0.4 | $2.3M | 544k | 4.16 | |
Egalet | 0.4 | $2.2M | 293k | 7.61 | |
Advance Auto Parts (AAP) | 0.3 | $2.2M | 15k | 149.15 | |
Advaxis | 0.3 | $2.1M | 200k | 10.69 | |
Ardelyx (ARDX) | 0.3 | $2.0M | 152k | 12.94 | |
Trillium Therapeutics, Inc. Cmn | 0.3 | $2.0M | 132k | 14.78 | |
Paratek Pharmaceuticals | 0.3 | $1.8M | 140k | 13.01 | |
Xenon Pharmaceuticals (XENE) | 0.3 | $1.8M | 228k | 8.10 | |
Summit Therapeutics Plc spons ads | 0.3 | $1.8M | 198k | 9.18 | |
Repros Therapeutics | 0.3 | $1.8M | 864k | 2.09 | |
Aduro Biotech | 0.3 | $1.7M | 140k | 12.43 | |
Keryx Biopharmaceuticals | 0.3 | $1.7M | 312k | 5.31 | |
Nivalis Therapeutics | 0.3 | $1.7M | 205k | 8.13 | |
Immune Design | 0.2 | $1.5M | 203k | 7.58 | |
Edge Therapeutics | 0.2 | $1.6M | 150k | 10.41 | |
Shire | 0.2 | $1.5M | 7.5k | 193.87 | |
Burlington Stores (BURL) | 0.2 | $1.5M | 19k | 81.03 | |
Pieris Pharmaceuticals (PIRS) | 0.2 | $1.5M | 810k | 1.83 | |
Vtv Therapeutics Inc- Cl A | 0.2 | $1.4M | 200k | 7.19 | |
Myokardia | 0.2 | $1.4M | 83k | 16.34 | |
Immunomedics | 0.2 | $1.3M | 400k | 3.25 | |
Ac Immune Sa (ACIU) | 0.2 | $1.3M | 80k | 16.47 | |
Palatin Technologies | 0.2 | $1.2M | 1.9M | 0.63 | |
Palo Alto Networks (PANW) | 0.2 | $1.1M | 7.1k | 159.39 | |
Sapiens Intl Corp N V | 0.2 | $1.0M | 81k | 12.77 | |
Arbutus Biopharma (ABUS) | 0.2 | $1.0M | 300k | 3.44 | |
Mirati Therapeutics | 0.2 | $992k | 150k | 6.61 | |
Oncobiologics | 0.1 | $850k | 200k | 4.25 | |
Arrowhead Pharmaceuticals (ARWR) | 0.1 | $735k | 100k | 7.35 | |
Ormat Technologies (ORA) | 0.1 | $370k | 7.6k | 48.43 | |
Alimera Sciences | 0.1 | $299k | 201k | 1.49 | |
Siteone Landscape Supply (SITE) | 0.1 | $288k | 8.0k | 35.91 | |
Mohawk Industries (MHK) | 0.0 | $220k | 1.1k | 200.00 | |
UnitedHealth (UNH) | 0.0 | $238k | 1.7k | 140.00 | |
Cable One (CABO) | 0.0 | $216k | 370.00 | 583.78 | |
Henry Schein (HSIC) | 0.0 | $163k | 1.0k | 163.00 | |
Lowe's Companies (LOW) | 0.0 | $212k | 2.9k | 72.11 | |
Ellomay Capital (ELLO) | 0.0 | $51k | 5.7k | 9.02 |